

"Global provider of specialty immunoassays and automated diagnostic systems for clinical laboratories"
IDS develops, manufactures and markets automated immunoassay systems and specialty test kits for clinical laboratories worldwide. With over 30 years of expertise in in-vitro diagnostics, the company creates solutions for endocrinology, autoimmunity, allergy, infectious diseases and therapeutic drug monitoring. Products include the IDS iSYS platform and chemiluminescence immunoassays. Founded in 1977 and headquartered in the UK, IDS serves laboratories through regional offices and distributors. Since joining Revvity in 2021, the company has integrated with Euroimmun. IDS improves laboratory efficiency and diagnostic outcomes, helping clinicians make informed decisions for patient care in bone health, kidney disease and hormone disorders.


300
Team Members
1977
Founded
Diagnostics
Sector
On-Site
Work Environment
Laboratories worldwide equipped with advanced diagnostic tools that enable faster, more accurate patient diagnoses and better treatment outcomes
IDS partners with clinical laboratories to provide high quality, innovative diagnostic solutions that improve laboratory efficiency and deliver fast, accurate results for diagnosis and therapy monitoring